Conference Coverage
Conference Coverage
In Prostate Cancer, Most Roads Lead to VA Pathway
The newly updated US Department of Veterans Affairs (VA) prostate cancer clinical pathway...
Conference Coverage
Clinical Controversy: Standard Dose or Baby TAM for Breast Cancer Prevention?
Docs debate which dose of tamoxifen is best for reducing breast cancer risk at the ESMO Breast Cancer Congress.
Conference Coverage
MUC-1 vaccine associated with notable overall survival rates in breast cancer
Patients with HER2-negative early breast cancer receive preoperative standard of care neoadjuvant treatment with or without tecemotide, in new...
Conference Coverage
Experts Focus on Quality-of-Life Data in Prostate Cancer
Trials presented at ASCO explore the effects of treatment suspension or intensification on health-related QoL and interventions to manage side...
Conference Coverage
AVAHO Mtg: Germline Testing Key for Vets With High-Risk PC
Attendees learn that about 10% of patients could benefit from testing
Conference Coverage
ESOPEC: FLOT Bests CROSS in Resectable Esophageal Cancer
Study results settle a long-standing debate about whether chemotherapy with FLOT before and after surgery, or neoadjuvant radiation plus CROSS...
Conference Coverage
Platinum Add-On Improves Survival in Early TNBC
Trial outcomes provide strong evidence for incorporating carboplatin into both the neoadjuvant and adjuvant settings in patients with early-stage...
Conference Coverage
Should ctDNA guide clinical decisions in GI cancers?
Data are maturing for colon cancer and emerging for pancreatic cancer, but experts say more work needs to be done.
Latest News
Rethinking Management of Skin Cancer in Older Patients
The dermatologist's risk assessment -- both staging and stratifying risk as it relates to specific outcomes such as recurrence, metastases, or...
Conference Coverage
Lung Cancer Expert at ASCO: From Fatal to ‘Chronic Disease’
Tony Shu-Kam Mok, MD, discusses latest KRAS G12C findings and more.
